BioTime (BTX) CEO Dr. Michael West to Present at World Stem Cell Summit 2012
11/29/2012 9:32:49 AM
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at the World Stem Cell Summit 2012 in West Palm Beach, Florida on Tuesday, December 4, 2012. Dr. West will be presenting in the session on “Developing Combination Products: Cells, Genes, and Devices” at 1:30 pm EST which will include an update on product development, including Renevia™, PanC-Dx™, and OpRegen®. The presentation will be made available on BioTime's website at www.biotimeinc.com.